Ipsen - October 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital
Werte in diesem Artikel
Monthly information relative to the total number of voting rights
and shares composing the share capital
(in accordance with Article L.233-8 II of the French Commercial Code and
Article 223-16 of the General Regulation of the Autorité des Marchés Financiers)
Market: Euronext Paris
ISIN Code: FR 0010259150
LEI: 549300M6SGDPB4Z94P11
| Date | Total number of shares composing the share capital | Total number of voting rights (1) |
| 31 October 2024 | 83,814,526 | Gross total* of voting rights: 132,135,791 |
| Net total** of voting rights: 131,036,178 |
(1) Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10).
* Gross total = total number of voting rights attached to the total number of shares, including the number of shares which benefit of double voting rights and the number of treasury shares. The « Gross total » is used as a basis for the calculation of threshold crossings.
** Net total = total number of voting rights attached to the total number of shares – shares without voting rights.
Attachment
Ausgewählte Hebelprodukte auf Ipsen
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ipsen
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu Ipsen
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu Ipsen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.11.2012 | IpsenAct neutral | Exane-BNP Paribas SA | |
| 01.11.2012 | IpsenAct hold | Société Générale Group S.A. (SG) | |
| 30.10.2012 | IpsenAct neutral | Exane-BNP Paribas SA | |
| 30.10.2012 | IpsenAct hold | Société Générale Group S.A. (SG) | |
| 25.10.2012 | IpsenAct neutral | Exane-BNP Paribas SA |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.08.2012 | IpsenAct outperform | Cheuvreux SA | |
| 30.01.2012 | IpsenAct buy | Société Générale Group S.A. (SG) | |
| 25.10.2011 | IpsenAct buy | Société Générale Group S.A. (SG) | |
| 03.10.2011 | IpsenAct buy | Société Générale Group S.A. (SG) | |
| 31.08.2011 | IpsenAct buy | Société Générale Group S.A. (SG) |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.11.2012 | IpsenAct neutral | Exane-BNP Paribas SA | |
| 01.11.2012 | IpsenAct hold | Société Générale Group S.A. (SG) | |
| 30.10.2012 | IpsenAct neutral | Exane-BNP Paribas SA | |
| 30.10.2012 | IpsenAct hold | Société Générale Group S.A. (SG) | |
| 25.10.2012 | IpsenAct neutral | Exane-BNP Paribas SA |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.03.2012 | IpsenAct underperform | Credit Suisse Group | |
| 10.10.2011 | IpsenAct sell | Citigroup Corp. | |
| 30.08.2011 | IpsenAct sell | Citigroup Corp. | |
| 12.07.2007 | Tercica underperform | Friedman, Billings Ramsey & Co |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ipsen nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen